Skip to content
Screener

GeneDx Holdings WGS GeneDx — Adjusted cost of services

Similar metrics at other companies

NCR Atleos logo
NATLSelf-Service Banking — Adjusted cost of services
$339M+12.3%
NCR Atleos logo
NATLNetwork — Adjusted cost of services
$207M+1.5%
NCR Atleos logo
NATLT&T — Adjusted cost of services
$28M-3.4%
First Advantage Corporation logo
FASterling — Less Adjusted Cost Of Services
$120.4M+6.9%
Trueblue logo
TBIService — Cost of Services
$318.54M+12.6%
UiPath logo
PATHSubscription services — Adjusted cost of revenue
$39.35M+17.9%

Other financials

Income statement

See full
Revenue$102.3M+17.4%
Gross profit$68.2M+16.6%
Operating income-$57.5M-1,163%
Net income-$63.3M-870%
EPS (diluted)-$2.16-839%

Balance sheet

See full
Cash & equivalents$94.9M-5.7%
Total debt$96.7M+82.5%
Total equity$254.1M-1.3%
Total assets$506.3M+13.4%

Cash flow

See full
Operating cash flow-$32.4M-418%
CapEx$6.5M+5.3%
Free cash flow-$38.9M-1,059%

Valuation

See full
Market cap$2.3B-27.6%
Enterprise value$2.3B-27.0%
P/S5.2×-3.6×

Profitability

See full
Gross margin69.6%+4.3pp
Operating margin-14.9%
Net margin-17.6%
FCF margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-30.4%
Debt / equity0.4×+0.2×
Current ratio3.1×-0.2×

Where this comes from

Reported directly by GeneDx Holdings in its filing.

Tagged under the XBRL concept wgs:AdjustedCostOfGoodSold.

The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001818331-26-000041
Line itemThree months ended March 31, 2026 / Gene DxThree months ended March 31, 2026 / OtherThree months ended March 31, 2026 / TotalThree months ended March 31, 2025 / Gene DxThree months ended March 31, 2025 / OtherThree months ended March 31, 2025 / Total
Revenue$101,496$758$102,254$87,115$87,115
Adjusted cost of services31,61358832,20127,39627,396
Adjusted gross profit(1)69,88317070,05359,71959,719
Reconciliations:
Depreciation and amortization1,4621,075
Stock-based compensation380168
Gross profit$68,211$58,476

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is GeneDx Holdings's genedx — adjusted cost of services?
GeneDx Holdings (WGS) reported genedx — adjusted cost of services of $31.61M in Q1 2026.
How has GeneDx Holdings's genedx — adjusted cost of services changed year-over-year?
GeneDx Holdings's genedx — adjusted cost of services increased by 15.4% year-over-year, from $27.4M to $31.61M.
What is the long-term trend for GeneDx Holdings's genedx — adjusted cost of services?
Over 2 years (2023 to 2025), GeneDx Holdings's genedx — adjusted cost of services has grown at a 6.8% compound annual growth rate (CAGR), from $106.98M to $122.1M.
What does genedx — adjusted cost of services mean?
Reflects the direct costs incurred by the GeneDx segment to deliver its diagnostic services, excluding certain non-recurring or non-cash items. This metric is used to evaluate the efficiency of the core operational delivery process.

Ask your AI about GeneDx Holdings's genedx — adjusted cost of services.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude